TGFB1 and idiopathic pulmonary fibrosis: Despite the growing body of evidence demonstrating the increased presence of activated platelets in clinical and animal studies of IPF, it is still unclear how platelets drive fibrotic disease progression and whether platelets represent a major source of profibrotic TGFβ1 in IPF.